Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03158090

The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,965 (estimated)
Sponsor
Ginkgo Leaf Center for Rare Disorders · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

This study is a prospective, noninteractive, observational, and longitudinal study aimed at assessing the treatment pattern and clinical outcome of acromegaly in China.

Detailed description

The study was designed to answer some of the most important questions about the treatment modalities of acromegaly, the relevance of these treatment modalities to patients' clinical outcomes and the economic impact of treatment programs on patients. These answers may be of great help to the treatment of these populations and may also help to make treatment and related health decisions in the future. This study only collects the patient's medical information during the study and does not interfere with the patient's treatment. Each patient will be assigned a unique patient identification number for the study. The sites will maintain a confidential decode list that enables the study staff at the site to link the assigned patient identification number with the patient's medical records for extraction of study-required data. These registries will be maintained following International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) and the respective local privacy laws and requirements.

Conditions

Interventions

TypeNameDescription
PROCEDURETransnasal butterfly surgeryThe patient will be treated in accordance with the advice of the local doctor in charge, and this study does not interfere with any treatment of the patient.
DRUGsandostatinThe patient will be treated in accordance with the advice of the local doctor in charge, and this study does not interfere with any treatment of the patient
RADIATIONradiotherapyThe patient will be treated in accordance with the advice of the local doctor in charge, and this study does not interfere with any treatment of the patient

Timeline

Start date
2017-12-15
Primary completion
2050-12-30
Completion
2051-01-30
First posted
2017-05-17
Last updated
2022-03-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03158090. Inclusion in this directory is not an endorsement.